In: European Journal of Nuclear Medicine and Molecular Imaging, 2012, vol. 39, no. 2, p. 344-353
|
In: European Heart Journal, 2013, vol. 34, no. 27, p. 2063-2073
|
In: European Journal of Cardio-Thoracic Surgery, 2007, vol. 32, no. 3, p. 403-408
|
In: European Heart Journal, 2009, vol. 30, no. 24, p. 3064-3073
|
In: European Heart Journal, 2009, vol. 30, no. 8, p. 978-986
|
In: European Heart Journal, 2011, vol. 32, no. 17, p. 2100-2108
|
In: European Journal of Cardio-Thoracic Surgery, 2012, vol. 41, no. 3, p. 612-616
|
In: European Heart Journal, 2009, vol. 30, no. 24, p. 2993-2999
|
In: British Journal of Nutrition, 2013, vol. 110, no. S1, p. S1-S30
|
In: Bioorganic & Medicinal Chemistry Letters, 2013, vol. 23, no. 22, p. 6068–6072
The development of RGD-based antagonist of αvβ3 integrin receptor has enhanced the interest in PET probes to image this receptor for the early detection of cancer, to monitor the disease progression and the response to therapy. In this work, a novel prosthetic group (N-(4-fluorophenyl)pent-4-ynamide or FPPA) for the 18F-labeling of an αvβ3 selective RGD-peptide was successfully prepared....
|